{"version":"1.0","provider_name":"GCRF Biopharma","provider_url":"https:\/\/research.kent.ac.uk\/gcrfbiopharma","author_name":"GCRF Biopharma","author_url":"https:\/\/research.kent.ac.uk\/gcrfbiopharma","title":"Jaraspim Narkpuk - GCRF Biopharma - Research at Kent","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"FY6NI93VPU\"><a href=\"https:\/\/research.kent.ac.uk\/gcrfbiopharma\/person\/jaraspim-narkpuk\/\">Jaraspim Narkpuk<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/research.kent.ac.uk\/gcrfbiopharma\/person\/jaraspim-narkpuk\/embed\/#?secret=FY6NI93VPU\" width=\"600\" height=\"338\" title=\"&#8220;Jaraspim Narkpuk&#8221; &#8212; GCRF Biopharma\" data-secret=\"FY6NI93VPU\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/research.kent.ac.uk\/gcrfbiopharma\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/research.kent.ac.uk\/gcrfbiopharma\/wp-content\/uploads\/sites\/1441\/2019\/10\/jaraspim.jpg","thumbnail_width":376,"thumbnail_height":376,"description":"Jaraspim completed her\u00a0Master\u2019s degree at King Mongkut\u2019s University of Technology Thonburi (KMUTT), studying functions of a\u00a0hypothetical protein of Baculovirus using RNA interference (RNAi). Since she joined\u00a0BIOTEC\u00a0in 2007,\u00a0Jaraspim has\u00a0developed\u00a0stable cell lines expressing influenza virus receptor to maximize virus vaccine production yield,\u00a0generated influenza virus expressing red fluorescence protein for\u00a0anti-influenza screening micro-neutralization assay development, and\u00a0studied\u00a0mechanism of intertypic interference [&hellip;]"}